Hepatic Fat Changes with Antisense Oligonucleotide Therapy Targeting ANGPTL3

A.Z, S.D.W, J.G.P, S.A.M., X.R., A.J., J.F.K., M.S.S., B.A.B., and N.A.M. are members of the TIMI Study Group, which has received institutional research grant support through Brigham and Women's Hospital from Abbott, Abiomed, Inc., Amgen, Anthos Therapeutics, ARCA Biopharma, Inc., AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, Ionis Pharmaceuticals, Inc., Janssen Research and Development, LLC, MedImmune, Merck, Novartis, Pfizer, Regeneron Pharmaceuticals, Inc., Roche, Saghmos Therapeutics,

Comments (0)

No login
gif